BTW
STJ

Boston Trust Walden’s St Jude Medical STJ Stock Holding History

Boston Trust Walden’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,440
Closed -$3.16M – 359
2016
Q4 		$3.16M Sell
39,440
-68,503
-63% -$5.44M 0.05% 237
2016
Q3 		$8.61M Sell
107,943
-8,750
-7% -$706K 0.14% 182
2016
Q2 		$9.1M Sell
116,693
-56,595
-33% -$4.04M 0.16% 178
2016
Q1 		$9.53M Sell
173,288
-620
-0.4% -$33.8K 0.17% 179
2015
Q4 		$10.7M Sell
173,908
-5,125
-3% -$323K 0.2% 170
2015
Q3 		$11.3M Sell
179,033
-12,151
-6% -$867K 0.19% 184
2015
Q2 		$14M Buy
191,184
+8,015
+4% +$579K 0.21% 166
2015
Q1 		$12M Buy
183,169
+11,050
+6% +$735K 0.18% 171
2014
Q4 		$11.2M Buy
172,119
+7,900
+5% +$509K 0.17% 173
2014
Q3 		$9.87M Buy
164,219
+18,175
+12% +$1.19M 0.15% 181
2014
Q2 		$10.1M Sell
146,044
-38,900
-21% -$2.52M 0.15% 176
2014
Q1 		$12.1M Sell
184,944
-2,400
-1% -$156K 0.18% 167
2013
Q4 		$11.6M Sell
187,344
-2,573
-1% -$149K 0.17% 173
2013
Q3 		$10.2M Sell
189,917
-1,250
-0.7% -$64.4K 0.16% 175
2013
Q2 		$8.72M Buy
+191,167
New +$8.28M 0.14% 175

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boston Trust Walden's STJ Position: Q1 2017 in Review

Boston Trust Walden sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 39,440 shares — an estimated $3.16M sold.

Boston Trust Walden first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $14M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Boston Trust Walden reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Boston Trust Walden sold 39,440 St Jude Medical shares in Q1 2017, an estimated $3.16M.
  • Boston Trust Walden first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Boston Trust Walden's St Jude Medical position peaked at $14M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Boston Trust Walden's 13F filing for Q1 2017, filed 24 Apr 2017.